← SynDRA
SD-0006
SynDRA canonical compound SYN0021695 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MAPK14 |
|---|
| Mechanism of action | p38 MAPK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
Cross-references
Synonyms
- SD-06
- SD0006
- PHA-666859
- SC-409
- P38-alpha kinase inhibitor (inflammation/diabetic retinopathy)
- P38-alpha kinase inhibitor (inflammation/diabetic retinopathy), Pfizer
- C57VF8YO91
- CHEBI:82712
- RefChem:182070
- DTXCID60382910
- MFCD17019341
- 3hl7
- UNII-C57VF8YO91
- orb1299956
- SCHEMBL4891685
- SD06
- SCHEMBL21067779
- SCHEMBL29395126
- GLXC-03363
- GLXC-10759
- HMS3244I19
- HMS3244I20
- HMS3244J19
- EX-A2504
- BDBM50315123
- s6502
- SD-06?
- AKOS030526762
- CS-0446
- NCGC00345832-01
- NCGC00345832-02
- AC-35456
- AS-16233
- DA-57754
- FC145174
- HY-11087
- SY347030
- NS00070344
Look up SD-0006 in the interactive SynDRA portal →